These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31660068)

  • 1. Tailored Black Phosphorus for Erythrocyte Membrane Nanocloaking with Interleukin-1
    Ou W; Byeon JH; Soe ZC; Kim BK; Thapa RK; Gupta B; Poudel BK; Ku SK; Yong CS; Kim JO
    Theranostics; 2019; 9(23):6780-6796. PubMed ID: 31660068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
    Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
    Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor environment differentiated "nanodepot" programmed for site-specific drug shuttling and combinative therapy on metastatic cancer.
    Dong Q; Zhang H; Han Y; Djamila A; Cheng H; Tang Z; Zhou J; Ding Y
    J Control Release; 2018 Aug; 283():59-75. PubMed ID: 29803613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers.
    Song M; Dong S; An X; Zhang W; Shen N; Li Y; Guo C; Liu C; Li X; Chen S
    J Control Release; 2022 May; 345():744-754. PubMed ID: 35381274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential delivery of VEGF siRNA and paclitaxel for PVN destruction, anti-angiogenesis, and tumor cell apoptosis procedurally via a multi-functional polymer micelle.
    Yang Y; Meng Y; Ye J; Xia X; Wang H; Li L; Dong W; Jin D; Liu Y
    J Control Release; 2018 Oct; 287():103-120. PubMed ID: 30144476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticles.
    Feng Q; Yu MZ; Wang JC; Hou WJ; Gao LY; Ma XF; Pei XW; Niu YJ; Liu XY; Qiu C; Pang WH; Du LL; Zhang Q
    Biomaterials; 2014 Jun; 35(18):5028-38. PubMed ID: 24680191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
    Yang X; Shi X; Ji J; Zhai G
    Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer.
    Swaminathan SK; Roger E; Toti U; Niu L; Ohlfest JR; Panyam J
    J Control Release; 2013 Nov; 171(3):280-7. PubMed ID: 23871962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1, 3β-Glucan anchored, paclitaxel loaded chitosan nanocarrier endows enhanced hemocompatibility with efficient anti-glioblastoma stem cells therapy.
    Singh PK; Srivastava AK; Dev A; Kaundal B; Choudhury SR; Karmakar S
    Carbohydr Polym; 2018 Jan; 180():365-375. PubMed ID: 29103516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
    Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
    Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.
    Song Y; Tang C; Yin C
    Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemotherapy mediated by thermosponge nanoparticles for synergistic anti-tumor effects.
    Zhao Y; Song Q; Yin Y; Wu T; Hu X; Gao X; Li G; Tan S; Zhang Z
    J Control Release; 2018 Jan; 269():322-336. PubMed ID: 29174440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional polymeric nanoparticles for combined chemotherapeutic and near-infrared photothermal cancer therapy in vitro and in vivo.
    Cheng FY; Su CH; Wu PC; Yeh CS
    Chem Commun (Camb); 2010 May; 46(18):3167-9. PubMed ID: 20424762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
    Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
    J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-dendrimer hybrid nanosystem as a novel delivery system for paclitaxel to treat ovarian cancer.
    Liu Y; Ng Y; Toh MR; Chiu GNC
    J Control Release; 2015 Dec; 220(Pt A):438-446. PubMed ID: 26551345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method for the Instant In-Flight Manufacture of Black Phosphorus to Assemble Core@Shell Nanocomposites for Targeted Photoimmunotherapy.
    Nguyen HT; Byeon JH; Phung CD; Pham LM; Ku SK; Yong CS; Kim JO
    ACS Appl Mater Interfaces; 2019 Jul; 11(28):24959-24970. PubMed ID: 31265222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.
    Bai F; Wang C; Lu Q; Zhao M; Ban FQ; Yu DH; Guan YY; Luan X; Liu YR; Chen HZ; Fang C
    Biomaterials; 2013 Aug; 34(26):6163-74. PubMed ID: 23706689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo.
    Zhu Z; Li Y; Li X; Li R; Jia Z; Liu B; Guo W; Wu W; Jiang X
    J Control Release; 2010 Mar; 142(3):438-46. PubMed ID: 19896997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctionality of lipid-core micelles for drug delivery and tumour targeting.
    Sawant RR; Torchilin VP
    Mol Membr Biol; 2010 Oct; 27(7):232-46. PubMed ID: 20929339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
    Patil Y; Sadhukha T; Ma L; Panyam J
    J Control Release; 2009 May; 136(1):21-9. PubMed ID: 19331851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.